Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI

Clin Nucl Med. 2012 Feb;37(2):e33-5. doi: 10.1097/RLU.0b013e3182335f33.

Abstract

A 28-year-old man with headache, nausea, and decreased vision had a left parieto-occipital tumor demonstrated by MRI. Postradical resection and histology showed a solid mass containing rhabdoid cells, 10% positive for Ki-67. After completing chemotherapy and radiotherapy treatment, follow-up MRI revealed possible tumoral recurrence. Cerebral F-18 FDG PET revealed no pathologic uptake, and C-11 methionine PET showed a pathologic low uptake. These findings suggested recurrence of a mild-grade aggressiveness tumor, which was confirmed by a second neurosurgical resection.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain Neoplasms / diagnostic imaging*
  • Fluorodeoxyglucose F18*
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Methionine*
  • Positron-Emission Tomography*
  • Rhabdoid Tumor / diagnostic imaging*

Substances

  • Fluorodeoxyglucose F18
  • carbon-11 methionine
  • Methionine